The Department of Immunology and Infectious Diseases (DIID) in the Division of Biologic Sciences (DBS) at the Harvard School of Public Health (HSPH) comprises a strong team of accomplished scientists who work on problems related to the immune response and to the biology, epidemiology and immunology of infectious diseases. DBS, established in 1993, is an umbrella structure that encompasses the biologic laboratory sciences in the areas of Immunology and Infectious Diseases, Cancer Cell Biology, Environmental Health, and Nutrition. The Ph.D. Program in Biological Sciences in Public Health (BPH) is located at HSPH and is offered by the Graduate School of Arts and Sciences. This pre-doctoral training grant competitive renewal application would support BPH students who choose to work in laboratories of faculty members of the Department of Immunology and Infectious Diseases. The BPH program provides a unique opportunity for training a cadre of leaders who possess expertise in the individual fields of biological research and a broad interdisciplinary knowledge of epidemiology and biostatistics. It has become increasingly evident that progress in disease prevention is optimally promoted by a close interaction between epidemiologists and laboratory scientists, where laboratory discoveries and epidemiological observations interact in an iterative manner to advance research in both fields. Furthermore, basic biological and epidemiological discoveries must be placed in a wide social context. This program encourages active collaboration among scientists who share complementary interests in developing closer linkages between laboratory research and field work- all with an eye to developing innovative approaches to prevention. Our training record in this grant period has been excellent as evidenced by the publication record and career paths of the pre-doctoral students supported. The 18 Faculty members in DIID are: the Program Director, Dr. L. Glimcher, gene expression in lymphocytes with a focus on cytokines, autoimmunity;Dr. M. Grusby, T helper cell differentiation with a focus on cytokine signal transduction, allergy;Dr. I-C. Ho, cytokine gene transcription;Dr. B. Bloom, tuberculosis, vaccine development, T cell activation;Dr. I. Kramnik, tuberculosis, immune mechanisms of protection;Dr. E. Rubin, molecular genetics of tuberculosis;Dr. D. Harn, leishmaniasis, schistosomiasis, immunology, molecular biology;Dr. A. Spielman, medical entomology, Lyme disease, erlichiosis;Dr. D. Wirth, malaria, leishmaniasis, drug resistance, vaccine development;Dr. B. Burleigh, cell biology, T. cruzi, malaria;Dr. M. Duraisingh, malaria;Dr. M. Essex, Drs. T-H. Lee, P. Kanki, HIV, co-infection with parasites, vaccine development. In addition, 4 faculty members with primary appointments at the Harvard Medical School will participate: Dr. J. Lieberman, HIV;Dr. H. Ploegh, cell biology and Dr. J. Sodroski, HIV, and Dr. A. Tzianabos, bacterial infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007638-10
Application #
7658694
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2000-09-01
Project End
2010-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
10
Fiscal Year
2009
Total Cost
$140,133
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Hicks, Nathan D; Yang, Jian; Zhang, Xiaobing et al. (2018) Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance. Nat Microbiol 3:1032-1042
Maiello, Pauline; DiFazio, Robert M; Cadena, Anthony M et al. (2018) Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison. Infect Immun 86:
Cadena, Anthony M; Fortune, Sarah M; Flynn, JoAnne L (2017) Heterogeneity in tuberculosis. Nat Rev Immunol 17:691-702
Cadena, Anthony M; Flynn, JoAnne L; Fortune, Sarah M (2016) The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome. MBio 7:e00342-16
Layre, Emilie; Lee, Ho Jun; Young, David C et al. (2014) Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c. Proc Natl Acad Sci U S A 111:2978-83
Aguilar, Ruth; Magallon-Tejada, Ariel; Achtman, Ariel H et al. (2014) Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow. Blood 123:959-66
Rooks, Michelle G; Veiga, Patrick; Wardwell-Scott, Leslie H et al. (2014) Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J 8:1403-17
McGee, Kathleen; Haim, Hillel; Korioth-Schmitz, Birgit et al. (2014) The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques. J Virol 88:21-40
Lin, Philana Ling; Ford, Christopher B; Coleman, M Teresa et al. (2014) Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20:75-9
Van Tyne, Daria; Uboldi, Alessandro D; Healer, Julie et al. (2013) Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs. Antimicrob Agents Chemother 57:2937-41

Showing the most recent 10 out of 45 publications